A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis

Area of Science:

• Genetics
• Neuroimmunology
• Molecular Biology

Background:

• Multiple sclerosis (MS) has numerous identified genetic risk alleles, but their functional impact on pathogenesis is often unclear.
• Understanding the mechanisms by which genetic variations influence MS is crucial for developing targeted therapies.

Purpose of the Study:

• To identify and characterize novel genetic variations in the CD24 promoter region associated with multiple sclerosis.
• To elucidate the functional consequences of identified genetic variants on CD24 gene regulation and MS progression.

Main Methods:

• Direct sequencing of the CD24 promoter region to identify single nucleotide polymorphisms (SNPs).
• Association studies in a cohort of MS patients and controls to identify risk-conferring haplotypes.
• Chromatin immunoprecipitation assays to investigate transcription factor binding.
• Analysis of CD24 transcript levels in relation to the identified genetic variant.

Main Results:

• Seven novel SNPs were identified in the CD24 promoter, with a 3-SNP haplotype showing significant association with MS risk (P=0.001).
• This risk haplotype was also linked to more rapid MS progression (P=0.016).
• The risk allele was shown to bind the transcription factor SP1, which is essential for the variant's heightened promoter activity, and CD24 transcript levels correlated with the variant in an SP1-dependent manner.

Conclusions:

• A novel risk haplotype in the CD24 promoter, associated with increased MS risk and progression, has been identified.
• The findings highlight a potential role for SP1-mediated transcriptional regulation of CD24 in MS pathogenesis.
• This study provides a molecular mechanism linking a specific genetic risk factor to MS development and progression.